http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 20 Aug 2025 17:23:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+18/25231348.html si-local-file:///var/storage/secattach/20250820/25231348.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+18/25231348.html Wed, 20 Aug 2025 17:23:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+18/25231348.html si-local-file:///var/storage/secattach/20250820/25231348.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+18/25231348.html Wed, 20 Aug 2025 17:23:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+18/25231348.html si-local-file:///var/storage/secattach/20250820/25231348.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+18/25231348.html Wed, 20 Aug 2025 17:23:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Vyome+Holdings%2C+Inc++++++++++++++++++/25231325.html si-local-file:///var/storage/secattach/20250820/25231325.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Vyome+Holdings%2C+Inc++++++++++++++++++/25231325.html Wed, 20 Aug 2025 17:21:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Vyome+Holdings%2C+Inc++++++++++++++++++/25231325.html si-local-file:///var/storage/secattach/20250820/25231325.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Vyome+Holdings%2C+Inc++++++++++++++++++/25231325.html Wed, 20 Aug 2025 17:21:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Vyome+Holdings%2C+Inc++++++++++++++++++/25231325.html si-local-file:///var/storage/secattach/20250820/25231325.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Vyome+Holdings%2C+Inc++++++++++++++++++/25231325.html Wed, 20 Aug 2025 17:21:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+13/25225767.html si-local-file:///var/storage/secattach/20250819/25225767.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+13/25225767.html Tue, 19 Aug 2025 17:30:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+13/25225767.html si-local-file:///var/storage/secattach/20250819/25225767.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+13/25225767.html Tue, 19 Aug 2025 17:30:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+13/25225767.html si-local-file:///var/storage/secattach/20250819/25225767.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vyome+Holdings%2C+Inc+++++++For%3A+Aug+13/25225767.html Tue, 19 Aug 2025 17:30:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Mergers+and+Acquisitions/Vyome+completes+merger+with+ReShape%2C+to+trade+as+HIND+on+NASDAQ/25209521.html <p>Vyome Therapeutics has completed its merger transaction with ReShape Lifesciences Inc. (NASDAQ: RSLS), according to a company statement. The combined entity will begin trading on NASDAQ under the name Vyome Holdings, Inc. with the ticker symbol "HIND" on August 15, 2025.</p> <p>Vyome describes itself as a clinical-stage healthcare company focused on immuno-inflammatory and rare diseases. The Cambridge, Massachusetts-based company operates across what it calls the US-India innovation corridor.</p> <p>The merger transaction was previously disclosed by both companies. ReShape Lifesciences had been trading on NASDAQ under the symbol RSLS prior to the completion of the merger.</p> <p>Following the merger close, shareholders of the combined http://www.streetinsider.com/Mergers+and+Acquisitions/Vyome+completes+merger+with+ReShape%2C+to+trade+as+HIND+on+NASDAQ/25209521.html Thu, 14 Aug 2025 19:19:12 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Mergers+and+Acquisitions/Vyome+completes+merger+with+ReShape%2C+to+trade+as+HIND+on+NASDAQ/25209521.html <p>Vyome Therapeutics has completed its merger transaction with ReShape Lifesciences Inc. (NASDAQ: RSLS), according to a company statement. The combined entity will begin trading on NASDAQ under the name Vyome Holdings, Inc. with the ticker symbol "HIND" on August 15, 2025.</p> <p>Vyome describes itself as a clinical-stage healthcare company focused on immuno-inflammatory and rare diseases. The Cambridge, Massachusetts-based company operates across what it calls the US-India innovation corridor.</p> <p>The merger transaction was previously disclosed by both companies. ReShape Lifesciences had been trading on NASDAQ under the symbol RSLS prior to the completion of the merger.</p> <p>Following the merger close, shareholders of the combined http://www.streetinsider.com/Mergers+and+Acquisitions/Vyome+completes+merger+with+ReShape%2C+to+trade+as+HIND+on+NASDAQ/25209521.html Thu, 14 Aug 2025 19:19:12 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Mergers+and+Acquisitions/Vyome+completes+merger+with+ReShape%2C+to+trade+as+HIND+on+NASDAQ/25209521.html <p>Vyome Therapeutics has completed its merger transaction with ReShape Lifesciences Inc. (NASDAQ: RSLS), according to a company statement. The combined entity will begin trading on NASDAQ under the name Vyome Holdings, Inc. with the ticker symbol "HIND" on August 15, 2025.</p> <p>Vyome describes itself as a clinical-stage healthcare company focused on immuno-inflammatory and rare diseases. The Cambridge, Massachusetts-based company operates across what it calls the US-India innovation corridor.</p> <p>The merger transaction was previously disclosed by both companies. ReShape Lifesciences had been trading on NASDAQ under the symbol RSLS prior to the completion of the merger.</p> <p>Following the merger close, shareholders of the combined http://www.streetinsider.com/Mergers+and+Acquisitions/Vyome+completes+merger+with+ReShape%2C+to+trade+as+HIND+on+NASDAQ/25209521.html Thu, 14 Aug 2025 19:19:12 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Press+Releases/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol “HIND.” </p><p> <b>About Vyome</b> </p><p> Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome’s immediate focus is leveraging its clinical-stage assets to transform the lives of patients http://www.streetinsider.com/Press+Releases/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html Thu, 14 Aug 2025 19:18:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Press+Releases/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol “HIND.” </p><p> <b>About Vyome</b> </p><p> Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome’s immediate focus is leveraging its clinical-stage assets to transform the lives of patients http://www.streetinsider.com/Press+Releases/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html Thu, 14 Aug 2025 19:18:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Press+Releases/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol “HIND.” </p><p> <b>About Vyome</b> </p><p> Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome’s immediate focus is leveraging its clinical-stage assets to transform the lives of patients http://www.streetinsider.com/Press+Releases/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html Thu, 14 Aug 2025 19:18:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Business+Wire/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol “HIND.” </p><p> <b>About Vyome</b> </p><p> Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome’s immediate focus is leveraging its clinical-stage assets to transform the lives of patients http://www.streetinsider.com/Business+Wire/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html Thu, 14 Aug 2025 19:18:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Business+Wire/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol “HIND.” </p><p> <b>About Vyome</b> </p><p> Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome’s immediate focus is leveraging its clinical-stage assets to transform the lives of patients http://www.streetinsider.com/Business+Wire/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html Thu, 14 Aug 2025 19:18:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/Business+Wire/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html <p> CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced that it has closed the previously disclosed transaction with ReShape Lifesciences Inc. (Nasdaq: RSLS). The post-merger company will trade at the open of trading on Friday, August 15, 2025 under the name Vyome Holdings, Inc. and the trading symbol “HIND.” </p><p> <b>About Vyome</b> </p><p> Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome’s immediate focus is leveraging its clinical-stage assets to transform the lives of patients http://www.streetinsider.com/Business+Wire/Vyome+closes+Merger+Transaction%2C+Will+Trade+on+Nasdaq+as+HIND+Tomorrow/25209520.html Thu, 14 Aug 2025 19:18:00 -0400 HIND O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ReShape+Lifesciences+++++++++++++++++++Filed+by%3A+L1+Capital+Global+Opportunities+Master+Fund%2C+Ltd./25209475.html si-local-file:///var/storage/secattach/20250814/25209475.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ReShape+Lifesciences+++++++++++++++++++Filed+by%3A+L1+Capital+Global+Opportunities+Master+Fund%2C+Ltd./25209475.html Thu, 14 Aug 2025 18:57:00 -0400 O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ReShape+Lifesciences+++++++++++++++++++Filed+by%3A+L1+Capital+Global+Opportunities+Master+Fund%2C+Ltd./25209475.html si-local-file:///var/storage/secattach/20250814/25209475.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ReShape+Lifesciences+++++++++++++++++++Filed+by%3A+L1+Capital+Global+Opportunities+Master+Fund%2C+Ltd./25209475.html Thu, 14 Aug 2025 18:57:00 -0400 O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ReShape+Lifesciences++++++For%3A+Jun+30/25208962.html si-local-file:///var/storage/secattach/20250814/25208962.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ReShape+Lifesciences++++++For%3A+Jun+30/25208962.html Thu, 14 Aug 2025 17:20:00 -0400 O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ReShape+Lifesciences++++++For%3A+Jun+30/25208962.html si-local-file:///var/storage/secattach/20250814/25208962.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ReShape+Lifesciences++++++For%3A+Jun+30/25208962.html Thu, 14 Aug 2025 17:20:00 -0400 O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ReShape+Lifesciences+++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25204717.html si-local-file:///var/storage/secattach/20250814/25204717.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ReShape+Lifesciences+++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25204717.html Thu, 14 Aug 2025 14:02:00 -0400 O.01228167 RSLS http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ReShape+Lifesciences+++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25204717.html si-local-file:///var/storage/secattach/20250814/25204717.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ReShape+Lifesciences+++++++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./25204717.html Thu, 14 Aug 2025 14:02:00 -0400 O.01228167 RSLS http://www.streetinsider.com/Mergers+and+Acquisitions/Vyome+gets+Nasdaq+approval+for+ReShape+merger%2C+to+trade+as+HIND/25194321.html <p>Vyome Therapeutics received Nasdaq approval for its merger with ReShape Lifesciences (NASDAQ: RSLS), with the combined company set to begin trading on August 15, 2025, under the name Vyome Holdings and ticker symbol "HIND."</p><p>The clinical-stage healthcare company focuses on immuno-inflammatory and rare diseases. ReShape's board declared a 1-for-4 reverse stock split effective at the start of trading on August 15, converting every four shares of common stock into one share. The new CUSIP number will be 92943X104.</p><p>The reverse split will not affect the post-merger ownership allocations between ReShape and Vyome shareholders, according to the press release statement.</p><p>Vyome operates clinical-stage assets http://www.streetinsider.com/Mergers+and+Acquisitions/Vyome+gets+Nasdaq+approval+for+ReShape+merger%2C+to+trade+as+HIND/25194321.html Wed, 13 Aug 2025 11:50:25 -0400 RSLS